Neurology prior authorization at Elevance Health
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Elevance Health neurology PA at a glance
Elevance Health reviews neurology PA submissions against its medical policy library, with rules drawn primarily from AAN (American Academy of Neurology) + AHS (American Headache Society) for migraine. Elevance Health-specific context: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.
Documentation packet — what to send
- MS or migraine diagnosis with ICD-10
- MS: MRI brain/spine within 6-12 months
- Migraine: headache diary (paper or app) covering ≥3 months
- Prior preventives with drug, dose, duration, and reason for discontinuation
- Disease severity score (EDSS for MS; MIDAS/HIT-6 for migraine)
Common denial patterns to pre-empt
Patterns observed in neurology across payers, and where Elevance Health's book of business overlaps:
- MS: McDonald criteria not documented
- MS: step therapy through DMTs before high-efficacy
- Migraine: insufficient prior preventive trials (typically 2 from different classes)
- Migraine: monthly migraine day frequency not documented
- Functional impairment / disability not characterised
- Step therapy
- Bariatric surgery prior auth
Appeal angles when Elevance Health denies
- AAN guideline citation by year
- MRI documentation of new lesions / clinical relapse for MS
- Headache diary documenting ≥4 monthly migraine days for CGRP class
- Failed step-therapy preventives with dose/duration/AE for each
Peer-to-peer prep
- Pull the most recent MRI report (lesion count, T2/FLAIR burden, new enhancement)
- Quote the AAN practice advisory by year
- For migraine: bring headache diary entries — payers reject 'frequent migraines' without quantified MMDs
- For high-efficacy MS DMTs: state explicitly which DMTs were tried and the failure (relapse, MRI activity, AE)
Drug-specific PA criteria at Elevance Health
Deep dives on each drug's PA criteria at Elevance Health:
Frequently asked questions
What documentation does Elevance Health need for neurology prior authorizations?
Elevance Health's PA packet for neurology typically includes: MS or migraine diagnosis with ICD-10; MS: MRI brain/spine within 6-12 months; Migraine: headache diary (paper or app) covering ≥3 months; Prior preventives with drug, dose, duration, and reason for discontinuation. AAN (American Academy of Neurology) + AHS (American Headache Society) for migraine citations strengthen the submission.
What's the turnaround at Elevance Health?
Elevance Health standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which neurology drugs does Elevance Health most often PA-restrict?
Top targets in neurology: ocrelizumab, natalizumab, ofatumumab, erenumab, galcanezumab. Each follows the per-drug step therapy + documentation requirements published in Elevance Health's medical policy library.
How do I prep a peer-to-peer with Elevance Health in neurology?
Pull the most recent MRI report (lesion count, T2/FLAIR burden, new enhancement) Quote the AAN practice advisory by year Have the policy URL and the patient's chart open before the call.
Generate a Neurology PA packet
Open ApprovalHelp — generate a neurology PA packet tailored to Elevance Health's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com